Immuneering Reports Compelling Preclinical Data on IMM-1-104 at AACR-NCI-EORTC International ...

Oelwein Daily Register

Oct 11, 2021

Preclinical Data Demonstrated Broad Antitumor Activity Across KRAS, NRAS and BRAF Mutant Tumor Models, Established Novel Mechanism of Action for its Dual MEK Inhibition and Showed…